Rezzayo 200 mg
Rezzayo 200 mg is a medicine authorised by Swissmedic under authorisation number 68394. The authorisation holder is Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 27 August 2026 and the authorisation is limited until 26 August 2031. ATC code J02AX08 places the medicine in the group Antimycotics for systemic use.
| Authorisation number | 68394 |
|---|---|
| Name | Rezzayo 200 mg |
| Full name | Rezzayo 200 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J02AX08 |
| First authorisation | 27 August 2026 |
| Authorisation validity | 26 August 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rezzayo 200 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 27 August 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | J02AX08 | 08.06.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Rezzayo 200 mg authorised in Switzerland?
Yes. Rezzayo 200 mg is authorised by Swissmedic under authorisation number 68394, data as of 01 September 2026. The authorisation is limited until 26 August 2031.
Which dispensing category does Rezzayo 200 mg have?
Rezzayo 200 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Rezzayo 200 mg?
The authorisation holder is Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.